Jonathan Kil

Jonathan Kil has over 20 years of experience in the pharmaceutical industry. Jonathan began their career in 1998 as the CEO of Otogene USA. In 2002, they took on the additional role of Chief Medical Officer at Sound Pharmaceuticals, Inc. and has served in both positions since then.

Jonathan Kil attended UC Irvine from 1985 to 1989, where they obtained a Bachelor of Science (BS) in Biological Sciences. Jonathan then moved on to Georgetown University School of Medicine, where they were an MD/PhD Candidate in Medicine and Otolaryngology from 1990 to 1992. After that, they pursued a MD/PhD Candidate in Medicine and Neuroscience at the University of Virginia School of Medicine from 1992 to 1996. Finally, they were a Senior Research Fellow in Otolaryngology at the University of Washington - School of Medicine from 1996 to 1998.